Xiaojie Tong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaojie Tong has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Fuxin Yi
Department of Neurosurgery, The First Affiliated Hospital of Liaoning Medical University, Liaoning 121001, P.R. China
1 shared publicationJianwu Qiu
Department of Neurosurgery, The First Affiliated Hospital of Liaoning Medical University, Liaoning 121001, P.R. China
1 shared publicationLei Tong
Department of Human Anatomy, Histology and Embryology, China Medical University, Shenyang, Liaoning 110001, P.R. China
1 shared publicationRui Wang
Department of Neurosurgery, The First Affiliated Hospital of Liaoning Medical University, Liaoning 121001, P.R. China
1 shared publicationWeimin NI
Department of Human Anatomy, Histology and Embryology, China Medical University, Shenyang, Liaoning 110001, P.R. China
1 shared publicationYan Fang
Department of Human Anatomy, Histology and Embryology, Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China
1 shared publication
Latest Publications
- Open Access
- 7 July 2015
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 12 (4) , 5086-5092
Girdin regulates the migration and invasion of glioma cells via the PI3K-Akt signaling pathway
Girdin, an actin‑binding protein, is associated with cell migration and is expressed at high levels in glioma cells. However, the association between girdin and the development of glioma remains to be elucidated. In the present study, short‑hairpin RNA technology was used to silence the gene expression of girdin. The effects of girdin silencing on glioma cell proliferation, migration and invasion were then assessed using a cell viability assay, wound‑healing assay, transwell invasion assay, reverse transcription‑quantitative polymerase chain reaction, western blot analysis and gelatin zymography. The results suggested that girdin silencing inhibited the proliferation, migration and invasion of glioma cells. In addition, the expression levels and activity of matrix metalloproteinase (MMP)‑2 and MMP‑9 were also affected by girdin silencing. Further mechanistic investigation indicated that girdin may regulate glioma cell migration and invasion through the phosphatidylinositol‑3‑kinase/protein kinase B (PI3K‑Akt) signaling pathway. Therefore, the results of the present study provide a theoretical foundation for the development of anticancer drugs.
- 7 July 2015
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 12 (4) , 5086-5092
Open AccessGirdin regulates the migration and invasion of glioma cells via the PI3K-Akt signaling pathway
Girdin, an actin‑binding protein, is associated with cell migration and is expressed at high levels in glioma cells. However, the association between girdin and the development of glioma remains to be elucidated. In the present study, short‑hairpin RNA technology was used to silence the gene expression of girdin. The effects of girdin silencing on glioma cell proliferation, migration and invasion were then assessed using a cell viability assay, wound‑healing assay, transwell invasion assay, reverse transcription‑quantitative polymerase chain reaction, western blot analysis and gelatin zymography. The results suggested that girdin silencing inhibited the proliferation, migration and invasion of glioma cells. In addition, the expression levels and activity of matrix metalloproteinase (MMP)‑2 and MMP‑9 were also affected by girdin silencing. Further mechanistic investigation indicated that girdin may regulate glioma cell migration and invasion through the phosphatidylinositol‑3‑kinase/protein kinase B (PI3K‑Akt) signaling pathway. Therefore, the results of the present study provide a theoretical foundation for the development of anticancer drugs.